JMJD6
Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6
Also known as: JMJD6_HUMAN, KIAA0585, PTDSR, PTDSR1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6NYC1
- Gene
- JMJD6
- Ensembl
- ENSG00000070495
- Chromosome
- 17
- Canonical length
- 403 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes a nuclear protein with a JmjC domain. JmjC domain-containing proteins are predicted to function as protein hydroxylases or histone demethylases. This protein was first identified as a putative phosphatidylserine receptor involved in phagocytosis of apoptotic cells; however, subsequent studies have indicated that it does not directly function in the clearance of apoptotic cells, and questioned whether it is a true phosphatidylserine receptor. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
403 residues, UniProt reviewed canonical sequence.
>Q6NYC1|JMJD6
1 MNHKSKKRIR EAKRSARPEL KDSLDWTRHN YYESFSLSPA AVADNVERAD ALQLSVEEFV
61 ERYERPYKPV VLLNAQEGWS AQEKWTLERL KRKYRNQKFK CGEDNDGYSV KMKMKYYIEY
121 MESTRDDSPL YIFDSSYGEH PKRRKLLEDY KVPKFFTDDL FQYAGEKRRP PYRWFVMGPP
181 RSGTGIHIDP LGTSAWNALV QGHKRWCLFP TSTPRELIKV TRDEGGNQQD EAITWFNVIY
241 PRTQLPTWPP EFKPLEILQK PGETVFVPGG WWHVVLNLDT TIAITQNFAS STNFPVVWHK
301 TVRGRPKLSR KWYRILKQEH PELAVLADSV DLQESTGIAS DSSSDSSSSS SSSSSDSDSE
361 CESGSEGDGT VHRRKKRRTC SMVGNGDTTS QDDCVSKERS SSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against JMJD6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 115 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 115 nTPM
- heart muscle: 39 nTPM
- skeletal muscle: 35 nTPM
- blood vessel: 34 nTPM
- colon: 30 nTPM
- adipose tissue: 29 nTPM
Single-cell type
- neutrophils: 295 nCPM
- neutrophil progenitors: 81 nCPM
- esophageal apical cells: 76 nCPM
- monocytes: 75 nCPM
- endometrial secretory cells: 73 nCPM
- late primary spermatocytes: 71 nCPM
Immune cell
- basophil: 51 nTPM
- eosinophil: 40 nTPM
- non-classical monocyte: 40 nTPM
- intermediate monocyte: 38 nTPM
- T-reg: 31 nTPM
- classical monocyte: 29 nTPM
Brain region
- white matter: 28 nTPM
- cerebellum: 26 nTPM
- thalamus: 22 nTPM
- cerebral cortex: 20 nTPM
- hypothalamus: 20 nTPM
- medulla oblongata: 20 nTPM
ReferencesPubMed · IEDB
Publications for JMJD6 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
2024 · Int J Mol Sci · RCR 0.6 · 3 citations - Prognostic and diagnostic significance of preoperative Jumonji domain‑containing 6 antibodies in colorectal cancer.
2023 · Oncol Lett · RCR 0.5 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.93
- gnomAD missense Z
- 1.48
- DepMap mean gene effect
- -0.46
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway
- chromatin remodeling
- erythrocyte development
- heart development
- kidney development
- lung development
- macrophage activation
- membraneless organelle assembly
- mRNA processing
- negative regulation of protein homooligomerization
- oxidative RNA demethylation
- phagocytosis
- positive regulation of DNA-templated transcription
- positive regulation of transcription by RNA polymerase II
- protein homooligomerization
- recognition of apoptotic cell
- regulation of mRNA splicing, via spliceosome
- retina development in camera-type eye
- RNA splicing
- sprouting angiogenesis
- T cell differentiation in thymus
- peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine
Molecular functions
- histone demethylase activity
- identical protein binding
- iron ion binding
- oxidative RNA demethylase activity
- P-TEFb complex binding
- protein demethylase activity
- RNA binding
- signaling receptor activity
- single-stranded RNA binding
- transcription regulator activator activity
- histone H3R2 demethylase activity
- histone H4R3 demethylase activity
- peptidyl-lysine 5-dioxygenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of JMJD6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads JMJD6 as an antibody target. Whether an autoantibody or antibody against JMJD6 could matter depends on whether native JMJD6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
JMJD6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label JMJD6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...